Filtered By:
Countries: Japan Health
This page shows you your search results in order of date. This is page number 18.
Order by Relevance | Date
Total 5271 results found since Jan 2013.
Minimally invasive surgery supercapsular percutaneously-assisted total hip (SuperPath) arthroplasty
CONCLUSIONS: Our data suggests that SuperPATH approach to THA for dysplastic OA was applicable to mildly dysplastic OA and achieved an early recovery of lower limb function.PMID:37326275 | DOI:10.23750/abm.v94i3.13922
Source: Acta Bio-Medica : Atenei Parmensis - June 16, 2023 Category: General Medicine Authors: Keisuke Hagio Kazuhisa Aikawa Source Type: research
FDA approves Roche ’s Columvi, the first and only bispecific antibody with a fixed-duration treatment for people with relapsed or refractory diffuse large B-cell lymphoma
Pivotal study showed durable responses, with a 56% overall response rate, a 43% complete response (remission) rate and a median duration of response of 1.5 years (18.4 months)1Given over a fixed period of time,Columvi provides patients with a treatment end date and potential time off treatmentColumvi is part of Roche ' s industry-leading portfolio of T-cell engaging bispecific antibodies in non-Hodgkin lymphoma, which also includes the recently approvedLunsumioto treat follicular lymphomaBasel, 16 June 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved ...
Source: Roche Investor Update - June 16, 2023 Category: Pharmaceuticals Source Type: news
Prescription patterns of analgesics in cancer patients with bone metastases in Japan: a retrospective database study
CONCLUSION: In Japanese cancer patients with bone metastases, acetaminophen, NSAIDs, and weak or strong opioids were commonly used; their use increased after SREs developed. Opioid use increased closer to death.PMID:37314600 | DOI:10.1007/s10147-023-02365-3
Source: Clinical Breast Cancer - June 14, 2023 Category: Cancer & Oncology Authors: Shingo Sato Hideyuki Tomitori Atsushi Okawa Kyoko Akano Source Type: research
